Transparency
Every Claim Is Checkable
Every number and every study we mention, listed with its source — so you can check it yourself.
- 66claims listed
- 70sources linked
- Oct 4, 2026last checked
Why we do thisShow the work, not just the claim
Health claims are easy to make and hard to check. So every number and every study we mention — on this site, on our product pages and in our Migraine Food Guide — is listed below, with the exact sentence, where we say it, and a link to the source: the study on PubMed (the U.S. National Library of Medicine’s database) or the official document it comes from. Read it, bring it to your doctor, make up your own mind.
Studies concern individual ingredients and approaches, not our product. STOP MIGRAINE RELIEF, RECOVERY and Relief Audio have not themselves been tested in clinical trials. When a study used a different form (taken by mouth, inhaled, a higher concentration) or a different condition (tension-type headache, surgery), we say so under “Keep in mind.”
Found a number on our site that isn’t here, or doesn’t match its source? Tell us at hello@trystopmigraine.com and we’ll correct it.
How to read itNot all evidence weighs the same
- Guideline or official documentExperts or regulators weigh all the available evidence.
- Systematic review or meta-analysisPools many studies. Only as good as the studies inside it.
- Randomized controlled trialCompares a treatment with a placebo or another option, assigned by chance. “Double-blind” means neither patients nor researchers know who got what.
- Open-label or pilot studyEveryone knows what they’re getting. A first signal, not proof.
- Survey, diary or observational studyDescribes what people experience. Shows links, not cause and effect.
- Lab or animal studyExplains how something might work. Doesn’t show that it works in people.
Size matters too: a trial of 35 people is a signal, not a verdict.
The claimsMigraine basics
What happens in a migraine, and why timing matters.
-
“Migraine isn't “just a headache.” It's a neurological event driven by the trigeminal nerve — the main sensory nerve of your head and face.”
- Where we say it
- Science page · Home page · RELIEF product page · Our articles
- Source
- Goadsby PJ et al. Physiological Reviews, 2017 · PubMed 28179394
Noseda R, Burstein R. Pain, 2013 · PubMed 23891892 - Study
- Two scientific reviews of how migraine works
-
“77% of people with migraine experience warning signs before the pain.”
- Where we say it
- Science page · Our articles · Migraine Food Guide, p. 8
- Source
- Laurell K et al. Cephalalgia, 2016 · PubMed 26643378
- Study
- Questionnaire study · 2,223 people with migraine (2,714 surveyed)
- Keep in mind
- Participants came from Finnish migraine families; the authors caution that the group was not fully representative of everyone with migraine. Yawning was the most common sign (34%).
-
“In an electronic-diary study, people predicted their headache correctly from 72% of their warning-sign entries; the most frequent signs were tiredness, trouble concentrating and a stiff neck.”
- Where we say it
- Migraine Food Guide, p. 8
- Source
- Giffin NJ et al. Neurology, 2003 · PubMed 12654956
- Study
- Diary study over 3 months · 120 patients recruited, 97 with usable data
- Keep in mind
- Patients were recruited because they already noticed warning signs, so this describes people who have them, not everyone with migraine.
-
“People with migraine tend to have slower stomach emptying — during and between attacks: in one small study, 149.9 minutes to empty half of it during an attack (188.8 minutes between attacks), versus 111.8 minutes in people without migraine.”
- Where we say it
- Science page · Our articles
- Source
- Aurora SK et al. Headache, 2006 · PubMed 16412152
- Study
- Gastric scan study · 10 people with migraine vs 10 without
- Keep in mind
- Very small study. Emptying was slow both during and between attacks — in fact a little less slow during an attack.
-
“The most-prescribed migraine pill reaches its peak blood level about 2.5 hours after you take it during an attack.”
- Where we say it
- Science page · Our articles
- Source
- Imitrex (sumatriptan) tablets, FDA prescribing information, section 12.3 · FDA label (DailyMed)
Tepper SJ, Johnstone MR. Medical Devices: Evidence and Research, 2018 (“sumatriptan as the most common” oral triptan) · PubMed 29760572 - Study
- Official drug label · review article
- Keep in mind
- The label compares about 2.5 hours during an attack with about 2.0 hours outside an attack.
-
“In a study of nearly 3,000 people diagnosed with “sinus headache,” 88% actually met the criteria for migraine.”
- Where we say it
- Science page · Our articles
- Source
- Schreiber CP et al. Archives of Internal Medicine, 2004 · PubMed 15364670
- Study
- Clinic screening study · 2,991 patients
- Keep in mind
- The 88% combines migraine (80%) and “migrainous disorder,” a close migraine-type diagnosis (8%).
-
“When that system activates, trigeminal nerve endings release a messenger called CGRP — the same molecule the newest prescription migraine drugs are designed to block.”
- Where we say it
- Our articles
- Source
- Goadsby PJ et al. Annals of Neurology, 1990 · PubMed 1699472
Ailani J et al. (American Headache Society). Headache, 2021 · PubMed 34160823 - Study
- Blood-sampling study during attacks · expert consensus statement
-
“If touch, hair or your pillow hurts during an attack, that's called cutaneous allodynia — a sign your trigeminal nerve is sensitized.”
- Where we say it
- Science page · Our articles
- Source
- Burstein R et al. Annals of Neurology, 2000 · PubMed 10805332
- Study
- Clinical study measuring skin pain thresholds during and outside attacks
- Keep in mind
- Allodynia was found in 79% of the patients studied.
-
“Aura usually lasts 5 to 60 minutes, and the headache follows within the hour.”
- Where we say it
- Our articles
- Source
- International Classification of Headache Disorders, 3rd edition (ICHD-3), 1.2 Migraine with aura · ICHD-3 criteria
- Study
- Official diagnostic criteria
- Keep in mind
- These are typical features used for diagnosis; some auras last longer, and the headache can also start during the aura.
-
“In a population study of 5,000 women, about 1 in 5 women with migraine (22%) had attacks in at least half of their periods.”
- Where we say it
- Our articles
- Source
- Vetvik KG et al. Cephalalgia, 2014 · PubMed 24101732
- Study
- Population study · 5,000 women screened
- Keep in mind
- All participants were aged 30 to 34.
-
“Across studies, menstrual migraine affects about 20–25% of women with migraine.”
- Where we say it
- Our articles
- Source
- Vetvik KG, MacGregor EA. Lancet Neurology, 2021 · PubMed 33600767
- Study
- Review
- Keep in mind
- In the general population; the share is higher among patients seen in headache clinics.
-
“The International Classification of Headache Disorders describes “menstrual migraine” as attacks that start between 2 days before and the 3rd day of your period, in at least 2 out of 3 cycles.”
- Where we say it
- Our articles
- Source
- ICHD-3, Appendix A1.1.1 · ICHD-3 criteria
- Study
- Official diagnostic criteria
- Keep in mind
- These criteria sit in the appendix, used mainly for research.
-
“Attacks cluster when estrogen falls before your period, and fewer happen while estrogen is rising.”
- Where we say it
- Our articles
- Source
- MacGregor EA et al. Neurology, 2006 · PubMed 16971700
- Study
- Hormone and diary study over 3 cycles · 38 women
- Keep in mind
- Small study.
-
“Women with migraine show a faster estrogen drop before their period than women without (40% vs. 30% in two days).”
- Where we say it
- Our articles
- Source
- Pavlović JM et al. Neurology, 2016 · PubMed 27251885
- Study
- Observational hormone study · 114 women with migraine, 223 without
-
“In one diary study, period migraines lasted 23.4 hours vs. 16.1 hours for other migraines.”
- Where we say it
- Our articles
- Source
- Pinkerman B, Holroyd K. Cephalalgia, 2010 · PubMed 20855364
- Study
- Electronic diary study · 107 women with menstrually-related migraine
-
“Another found they lasted on average 10.6 hours longer and came with severe nausea more often.”
- Where we say it
- Our articles
- Source
- Vetvik KG et al. Cephalalgia, 2015 · PubMed 25754177
- Study
- Diary study · 56 women diagnosed with menstrual migraine
- Keep in mind
- The difference was found only in women who meet the criteria for menstrual migraine.
-
“Pain-free at 2 hours after treatment: 13.5% of menstrual attacks vs. 32.9% of other attacks.”
- Where we say it
- Our articles
- Source
- Granella F et al. Cephalalgia, 2004 · PubMed 15315526
- Study
- Diary study · 64 women seen in headache centers
-
“They were also more likely to come back within 24 hours (36.0% vs. 19.6%).”
- Where we say it
- Our articles
- Source
- Pinkerman B, Holroyd K. Cephalalgia, 2010 · PubMed 20855364
- Study
- Electronic diary study · 107 women
- Keep in mind
- Measured after a 4-hour pain-free response.
The claimsRELIEF
The ingredients of our first-sign roll-on: menthol, peppermint oil, German chamomile, feverfew, magnesium.
-
“Menthol activates TRPM8 — the skin's cold receptor, first identified in trigeminal nerve cells.”
- Where we say it
- Science page · RELIEF product page · Our articles
- Source
- McKemy DD et al. Nature, 2002 · PubMed 11882888
Peier AM et al. Cell, 2002 · PubMed 11893340 - Study
- Laboratory studies
- Keep in mind
- Done on cells and nerve cells in the lab, not in people.
-
“Cold-sensing nerve endings sit in the very top layer of your skin — right where you roll it on.”
- Where we say it
- Science page · Our articles
- Source
- Dhaka A et al. Journal of Neuroscience, 2008 · PubMed 18199758
- Study
- Laboratory study
- Keep in mind
- Animal study (mice).
-
“Menthol heightens the perception of cooling.”
- Where we say it
- Our articles
- Source
- Green BG. Somatosensory & Motor Research, 1992 · PubMed 1414120
- Study
- Laboratory study in people
- Keep in mind
- Tested on forearm skin.
-
“Menthol has been tested on the forehead and temples in a randomized, placebo-controlled migraine trial.”
- Where we say it
- Science page · RELIEF product page · Our articles
- Source
- Borhani Haghighi A et al. International Journal of Clinical Practice, 2010 · PubMed 20456191
- Study
- Randomized, triple-blind, placebo-controlled crossover trial · 35 patients, 118 attacks
- Keep in mind
- The trial used a 10% menthol solution, a higher concentration than in our roll-on. Small study.
-
“Researchers at the Jefferson Headache Center tested a menthol gel at the base of the skull during migraine attacks.”
- Where we say it
- Science page · Our articles
- Source
- St Cyr A et al. Frontiers in Neurology, 2015 · PubMed 25699012
- Study
- Open-label pilot study · 25 patients
- Keep in mind
- No placebo group, so the result can't be separated from expectation.
-
“In a double-blind trial, 10% peppermint oil on the forehead and temples worked as well as 1,000 mg of acetaminophen for tension-type headache — with relief starting at 15 minutes.”
- Where we say it
- Science page · RELIEF product page · Home page · Our articles
- Source
- Göbel H et al. Nervenarzt, 1996 · PubMed 8805113
- Study
- Randomized, double-blind, placebo-controlled crossover trial · 41 patients, 164 headaches
- Keep in mind
- Tension-type headache, not migraine. The trial used 10% peppermint oil in alcohol.
-
“Peppermint oil on the skin is recognized by the European Medicines Agency for the relief of tension-type headache.”
- Where we say it
- Science page · Our articles
- Source
- European Medicines Agency, herbal monograph Mentha × piperita L., aetheroleum (EMA/HMPC/522410/2013) · EMA monograph
- Study
- Official regulatory monograph (“well-established use”)
- Keep in mind
- The exact wording is “mild tension-type headache,” for adults (not under 18).
-
“A randomized, double-blind trial in Neurological Sciences found a topical chamomile preparation reduced migraine pain, nausea and light sensitivity within 30 minutes.”
- Where we say it
- Science page · RELIEF product page · Home page · Our articles
- Source
- Zargaran A et al. Neurological Sciences, 2018 · PubMed 29808331
- Study
- Randomized, double-blind, placebo-controlled crossover trial · 100 enrolled, 72 completed
- Keep in mind
- The trial used a chamomile oleogel, not our roll-on.
-
“Menthol and chamomile: the two plant actives with positive clinical findings for migraine attacks in a 2020 systematic review.”
- Where we say it
- Science page · Home page · Our articles
- Source
- Lopresti AL et al. Phytotherapy Research, 2020 · PubMed 32310327
- Study
- Systematic review · 19 randomized trials
- Keep in mind
- The review calls these findings preliminary and notes a high risk of bias in many studies.
-
“Feverfew (Tanacetum parthenium): its MIG-99 extract was rated “probably effective” for migraine prevention by the American Academy of Neurology and the American Headache Society.”
- Where we say it
- Our articles
- Source
- Holland S et al. (AAN/AHS guideline). Neurology, 2012 · PubMed 22529203
- Study
- Clinical practice guideline (Level B)
- Keep in mind
- Oral extract, not applied to the skin.
-
“In a 16-week trial it lowered monthly attacks versus placebo.”
- Where we say it
- Our articles
- Source
- Diener HC et al. Cephalalgia, 2005 · PubMed 16232154
- Study
- Randomized, double-blind, placebo-controlled trial · 170 patients
- Keep in mind
- Oral extract. Attacks fell by 1.9 a month vs 1.3 on placebo.
-
“Its active compound, parthenolide, reduced CGRP release in lab studies.”
- Where we say it
- Our articles
- Source
- Materazzi S et al. Pain, 2013 · PubMed 23933184
- Study
- Laboratory study
- Keep in mind
- Done in cells and rodents.
-
“Magnesium carries a “strong recommendation” for migraine prevention from the Canadian Headache Society.”
- Where we say it
- Our articles
- Source
- Pringsheim T et al. Canadian Journal of Neurological Sciences, 2012 · PubMed 22683887
- Study
- Clinical practice guideline
- Keep in mind
- Magnesium citrate taken by mouth.
-
“In a double-blind trial, oral magnesium cut attack frequency by 41.6%, versus 15.8% on placebo.”
- Where we say it
- Our articles · Migraine Food Guide, p. 14
- Source
- Peikert A et al. Cephalalgia, 1996 · PubMed 8792038
- Study
- Randomized, double-blind, placebo-controlled trial · 81 patients
- Keep in mind
- 600 mg a day by mouth; 18.6% had diarrhea.
-
“Magnesium deficiency may affect up to half of people with migraine.”
- Where we say it
- Our articles
- Source
- Mauskop A, Varughese J. Journal of Neural Transmission, 2012 · PubMed 22426836
- Study
- Review
- Keep in mind
- An expert review, not a measurement study.
-
“In a double-blind, placebo-controlled study of women with menstrual migraine, oral magnesium taken in the second half of the cycle reduced headache days; the women also had lower magnesium levels inside their cells than controls.”
- Where we say it
- Our articles · Migraine Food Guide, p. 17
- Source
- Facchinetti F et al. Headache, 1991 · PubMed 1860787
- Study
- Double-blind, placebo-controlled trial · 20 women
- Keep in mind
- Very small study; oral magnesium.
The claimsRECOVERY
The migraine hangover, and why our day-after roll-on is lavender-free.
-
“The pain is gone, but you're not back. Neurologists call it the postdrome — patients call it the migraine hangover.”
- Where we say it
- Science page · RECOVERY product page · Our articles
- Source
- Giffin NJ et al. Neurology, 2016 · PubMed 27335112
Ng-Mak DS et al. Headache, 2011 · PubMed 21198571 - Study
- Diary study · interview study with patients
- Keep in mind
- In the interviews, patients' own words were “headache hangover” and “wiped out.”
-
“81% of people with migraine have symptoms after the pain ends — exhaustion, brain fog, a stiff neck.”
- Where we say it
- Science page · RECOVERY product page · Duo product page · Our articles
- Source
- Thuraiaiyah J et al. Journal of Headache and Pain, 2024 · PubMed 38383318
Giffin NJ et al. Neurology, 2016 (most frequent symptoms: tiredness, difficulty concentrating, stiff neck) · PubMed 27335112 - Study
- Cross-sectional study · 631 people with migraine; electronic diary study · 120 patients
- Keep in mind
- 80.7% reported at least one symptom when shown a list of 16 (66.7% without the list). Patients came from a headache center.
-
“It lasts 25 hours on average.”
- Where we say it
- Science page
- Source
- Kelman L. Cephalalgia, 2006 · PubMed 16426278
- Study
- Clinic study · 827 patients
- Keep in mind
- Average duration (25.2 hours) among patients who had a postdrome; 88% had one lasting 24 hours or less.
-
“Just as long, no matter which medication was taken.”
- Where we say it
- RECOVERY product page
- Source
- Giffin NJ et al. Neurology, 2016 · PubMed 27335112
Carvalho IV et al. Clinical Neurology and Neurosurgery, 2022 · PubMed 35985096 - Study
- Diary study · 120 patients; questionnaire study · 100 patients
- Keep in mind
- Refers to how long the postdrome lasts: no link was found with the medication taken for the headache.
-
“82.8% say it affects their quality of life.”
- Where we say it
- Science page
- Source
- Carvalho IV et al. Clinical Neurology and Neurosurgery, 2022 · PubMed 35985096
- Study
- Questionnaire study · 100 patients with migraine
- Keep in mind
- Patients from one hospital clinic.
-
“Neurologists call it the least studied phase of migraine.”
- Where we say it
- Science page
- Source
- Bose P, Goadsby PJ. Current Opinion in Neurology, 2016 · PubMed 26886356
- Study
- Review
-
“Nearly half of people with migraine are sensitive to smells, and for 40% an odor can trigger an attack.”
- Where we say it
- RECOVERY product page · Our articles
- Source
- Briggs EE et al. World Journal of Otorhinolaryngology – Head and Neck Surgery, 2025 · PubMed 42500087
- Study
- Meta-analysis · 58 studies, 22,299 patients
- Keep in mind
- The authors note the true rate is hard to pin down, because studies were included only if they reported on smell sensitivity.
-
“47.8% of people with migraine have osmophobia (sensitivity to smells), and for 40.1% an odor can trigger an attack — perfume being the #1 odor trigger.”
- Where we say it
- RECOVERY product page
- Source
- Briggs EE et al. 2025 · PubMed 42500087
- Study
- Meta-analysis · 58 studies, 22,299 patients
- Keep in mind
- Same limit as above.
-
“RECOVERY is a light, fresh blend of rosemary, sweet orange, ginger, peppermint, German chamomile and cardamom: aromas studied in randomized trials for alertness and for queasiness.”
- Where we say it
- Our articles
- Source
- Moss M et al. International Journal of Neuroscience, 2003 (rosemary) · PubMed 12690999
Moss M et al. International Journal of Neuroscience, 2008 (peppermint) · PubMed 18041606
Hunt R et al. Anesthesia & Analgesia, 2013 (ginger, blend with cardamom) · PubMed 22392970
Khatiban M et al. Journal of PeriAnesthesia Nursing, 2022 (cardamom) · PubMed 35581106 - Study
- Randomized trials of inhaled aromas · 144, 144, 301 and 70 participants
- Keep in mind
- Alertness was tested in healthy volunteers and queasiness after surgery — not in migraine, and not with our product.
The claimsRelief Audio
Guided self-hypnosis and binaural tones.
-
“In a randomized trial of 43 people with migraine, those who listened to self-hypnosis sessions as MP3s reduced their headache disability score by 48%, versus 2% on the waiting list. Attack frequency and intensity did not differ significantly.”
- Where we say it
- Relief Audio page · Science page
- Source
- Flynn N. International Journal of Clinical and Experimental Hypnosis, 2019 · PubMed 31251706
- Study
- Randomized trial vs waiting list · 43 participants
- Keep in mind
- Small study, and the comparison group received nothing (not a placebo audio).
-
“A 2026 systematic review of 9 studies (406 participants) found hypnosis consistently reduced migraine symptoms, while noting methodological limits.”
- Where we say it
- Relief Audio page · Science page
- Source
- Cardinal E et al. Complementary Therapies in Medicine, 2026 · PubMed 41974234
- Study
- Systematic review · 9 studies, 406 participants
- Keep in mind
- No pooled analysis was possible because the studies were too different.
-
“In a 2025 meta-analysis of trials in surgical settings, binaural-beat audio reduced anxiety compared with neutral audio.”
- Where we say it
- Relief Audio page
- Source
- Xiong J et al. Complementary Therapies in Medicine, 2025 · PubMed 41176178
- Study
- Meta-analysis · 15 randomized trials
- Keep in mind
- Patients around surgery, not people with migraine. Results varied a lot between trials.
-
“Binaural stimulation has also been studied as a 3-month evening routine at a headache center in Milan (preliminary results).”
- Where we say it
- Relief Audio page · Science page
- Source
- Lovati C et al. Neurological Sciences, 2019 · PubMed 30838547
- Study
- Short report of preliminary results
- Keep in mind
- No figures are given in the summary.
The claimsFood Guide
A selection of the numbers in our Migraine Food Guide. The PDF lists all 72 references.
-
“At a headache center in Atlanta, 1,207 patients rated their triggers: 57% named not eating — behind only stress and hormones. Specific foods? 27%.”
- Where we say it
- Migraine Food Guide, p. 4
- Source
- Kelman L. Cephalalgia, 2007 · PubMed 17403039
- Study
- Clinic survey · 1,207 patients
- Keep in mind
- Self-reported triggers; “hormones” was asked of women only.
-
“In 32 people with migraine observing Ramadan, migraine days rose from 3.7 in a normal month to 9.4 during the fasting month.”
- Where we say it
- Migraine Food Guide, p. 4
- Source
- Abu-Salameh I et al. Journal of Headache and Pain, 2010 · PubMed 20652352
- Study
- Observational study · 32 people
- Keep in mind
- Small study.
-
“In a trial at the Jefferson Headache Center, 18 of 34 people with fasting-triggered migraine developed a headache during a 20-hour fast while taking a placebo.”
- Where we say it
- Migraine Food Guide, p. 4
- Source
- Latsko M et al. Headache, 2011 · PubMed 21269298
- Study
- Randomized trial (placebo arm) · 74 randomized
-
“People who usually had no caffeine, one to two servings, or three to four servings a day had similar headache frequency: 7.1, 7.4 and 5.9 headache days a month.”
- Where we say it
- Migraine Food Guide, p. 5
- Source
- Mittleman MR et al. Headache, 2024 · PubMed 38318677
- Study
- Prospective diary cohort · 101 adults with episodic migraine
-
“Adults who usually drank about 235 mg a day (roughly 2.5 cups of coffee) were switched to placebo capsules without knowing it. 52% got a moderate or severe headache.”
- Where we say it
- Migraine Food Guide, p. 5
- Source
- Silverman K et al. New England Journal of Medicine, 1992 · PubMed 1528206
- Study
- Double-blind study · 62 adults
- Keep in mind
- Adults without migraine.
-
“The water group's migraine-specific quality-of-life score improved, and 47% felt “much improved,” versus 25% in the comparison group. But the number of days with moderate headache did not change.”
- Where we say it
- Migraine Food Guide, p. 7
- Source
- Spigt M et al. Family Practice, 2012 · PubMed 22113647
- Study
- Randomized trial · 102 patients
-
“In 63 women with chronic headache, chocolate was no more likely than carob (a look-alike) to bring on a headache.”
- Where we say it
- Migraine Food Guide, p. 8
- Source
- Marcus DA et al. Cephalalgia, 1997 · PubMed 9453274
- Study
- Double-blind provocation study · 63 women
-
“A 2020 review found that in 23 of 25 surveys, between 1.3% and 33% of people reported chocolate as a trigger, while all three blinded provocation studies were negative.”
- Where we say it
- Migraine Food Guide, p. 8
- Source
- Nowaczewska M et al. Nutrients, 2020 · PubMed 32110888
- Study
- Review
-
“A meta-analysis of 85 studies and 27,122 people found that about 81% endorse at least one trigger.”
- Where we say it
- Migraine Food Guide, p. 9
- Source
- Pellegrino ABW et al. Cephalalgia, 2018 · PubMed 28825314
- Study
- Meta-analysis · 85 studies
- Keep in mind
- Includes people with migraine or tension-type headache.
-
“When Danish researchers exposed 27 people to the triggers they themselves had reported (bright light, intense exercise), only 3 (11%) developed their usual aura attack.”
- Where we say it
- Migraine Food Guide, p. 9
- Source
- Hougaard A et al. Neurology, 2013 · PubMed 23345632
- Study
- Provocation study · 27 people with migraine with aura
-
“35.6% of 2,197 people named alcohol; red wine was the most cited drink (77.8% of them). Red wine consistently led to an attack in only 8.8%.”
- Where we say it
- Migraine Food Guide, p. 9
- Source
- Onderwater GLJ et al. European Journal of Neurology, 2019 · PubMed 30565341
- Study
- Online questionnaire · 2,197 people with migraine
- Keep in mind
- Self-reported.
-
“In NEJM, 40 self-identified reactors had headaches after 35% of aspartame doses vs. 45% after placebo.”
- Where we say it
- Migraine Food Guide, p. 9
- Source
- Schiffman SS et al. New England Journal of Medicine, 1987 · PubMed 3657889
- Study
- Double-blind crossover trial · 40 people
-
“In 100 people with migraine and low levels of the enzyme that breaks down histamine (DAO), a DAO supplement shortened attacks from 6.1 to 4.8 hours; placebo went from 7.5 to 6.7 hours.”
- Where we say it
- Migraine Food Guide, p. 10
- Source
- Izquierdo-Casas J et al. Clinical Nutrition, 2019 · PubMed 29475774
- Study
- Randomized, double-blind trial · 100 patients
- Keep in mind
- Only in people with low DAO levels.
-
“Compared with the control diet, H3-L6 cut headache days by 4.0 a month and total headache time by 1.7 hours a day; H3 alone cut 2.0 days and 1.3 hours. The headache-impact questionnaire, though, didn't improve significantly.”
- Where we say it
- Migraine Food Guide, p. 11
- Source
- Ramsden CE et al. BMJ, 2021 · PubMed 34526307
- Study
- Randomized controlled trial · 182 adults, 16 weeks
- Keep in mind
- One trial, not yet replicated; food was supplied to participants.
-
“In a Belgian randomized trial of 55 people, 400 mg a day for 3 months halved headache days in 59% of participants versus 15% on placebo.”
- Where we say it
- Migraine Food Guide, p. 15
- Source
- Schoenen J et al. Neurology, 1998 · PubMed 9484373
- Study
- Randomized, placebo-controlled trial · 55 patients
- Keep in mind
- Riboflavin (vitamin B2) supplement by mouth.
-
“In a Swiss trial of 42 people, 100 mg [of CoQ10] three times a day halved attack frequency in 47.6% vs. 14.4% on placebo, in the third month.”
- Where we say it
- Migraine Food Guide, p. 15
- Source
- Sándor PS et al. Neurology, 2005 · PubMed 15728298
- Study
- Randomized, double-blind, placebo-controlled trial · 42 patients
- Keep in mind
- Supplement by mouth; small study.
-
“In a small scan study of 10 people with migraine, stomach emptying was delayed both during and between attacks compared with people without migraine.”
- Where we say it
- Migraine Food Guide, p. 16
- Source
- Aurora SK et al. Headache, 2006 · PubMed 16412152
- Study
- Gastric scan study · 10 vs 10 people
- Keep in mind
- Very small study.
-
“In a 3-month diary study of 327 people, menstruation raised the risk of an attack by up to 96%; every other factor studied changed it by less than 35%.”
- Where we say it
- Migraine Food Guide, p. 17
- Source
- Wöber C et al. (PAMINA). Cephalalgia, 2007 · PubMed 17376107
- Study
- Prospective diary study · 327 people
-
“In a review of 40 studies, about 26% of adults with celiac disease had headaches…”
- Where we say it
- Migraine Food Guide, p. 13
- Source
- Zis P et al. Nutrients, 2018 · PubMed 30301194
- Study
- Systematic review and meta-analysis · 40 studies
These statements have not been evaluated by the Food and Drug Administration. STOP MIGRAINE products are not intended to diagnose, treat, cure, or prevent any disease. Studies cited concern individual ingredients and approaches, not our products. This page is for information only and is not medical advice; talk to your healthcare provider about your migraine treatment.